Sign in
SCHEDULE 13G/A

Statement of Beneficial Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0000935836-26-000590

Stakes reported in this filing

Reporting person Shares Of the class
EcoR1 Capital, LLC 3,028,116 2.9%
Oleg Nodelman 3,028,116 2.9%
EcoR1 Capital Fund Qualified, L.P. 2,885,435 2.8%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13G_X02/primary_doc.xml…